Optimal induction chemotherapeutic regimen followed by concurrent chemotherapy plus intensity-modulated radiotherapy as first-line therapy for locoregionally advanced nasopharyngeal carcinoma

doi:10.1097/MD.0000000000022283

HFCAS OpenIR

	Optimal induction chemotherapeutic regimen followed by concurrent chemotherapy plus intensity-modulated radiotherapy as first-line therapy for locoregionally advanced nasopharyngeal carcinoma
	Wang, Fangzheng 1,2,3,4; Jiang Chuner 1,5; Wang Lei 1,2,3,4; Yan Fengqin 1,2,3,4; Ye Zhimin 1,2,3,4; Sun Quanquan 1,2,3,4; Liu Tongxin 1,2,3,4; Fu Zhenfu 1,2,3,4; Jiang Yangming 6
	2020-09-25
发表期刊	MEDICINE
ISSN	0025-7974
通讯作者	Wang, Fangzheng(wangfz76@126.com) ; Jiang Yangming()
摘要	For patients with locoregionally advanced nasopharyngeal carcinoma (NPC), induction chemotherapy (IC) regimens based on TPF (docetaxel, cisplatin, and 5-fluorouracil), TP (docetaxel and cisplatin), and GP (gemcitabine and cisplatin) have shown excellent survival outcomes as the first-line therapy; however, no trials comparing the efficacy and safety of TPF, TP, and GP have been reported. We report 2 phase II trials comparing the treatment outcomes and side effects of 3 different IC regimens followed by concurrent chemoradiotherapy in locoregionally advanced patients with NPC. A total of 206 locoregionally advanced patients with NPC treated with a combination treatment from January 2012 to January 2014 were enrolled in the 2 studies. The patients received TPF-, TP-, and GP-based IC regimens every 3 weeks, followed by intensity-modulated radiotherapy and concurrent therapy with cisplatin every 3 weeks. After a median follow-up duration of 47 months (10-60 months), the 3-year local recurrence-free survival, regional recurrence-free survival, distant metastases-free survival, progression-free survival, and overall survival rates were 96.4%, 100%, 87.7%, 86%, and 94.7% in the TPF arm; 91.7%, 95.9%, 91.9%, 85.2%, and 92% in the TP arm; 98.6%, 100%, 89.0%, 87.6%, and 89.2% in the GP arm. The survival differences among the 3 arms were not statistically significant (P> .05). The multivariate analysis demonstrated that the IC regimen was not an independent prognostic factor for any survival outcomes. The patients in the TP arm experienced significantly lower grade 3/4 toxicities than the patients in the other 2 arms. TP-based IC regimen has similar efficacy compared with TPF- and GP-based IC regimens; however, TP-based IC regimen has a lower toxicity profile.
关键词	concurrent chemotherapy induction chemotherapy intensity-modulated radiotherapy nasopharyngeal carcinoma prognosis toxicity
DOI	10.1097/MD.0000000000022283
关键词[WOS]	COMPARING NEOADJUVANT CHEMOTHERAPY ; PHASE-II TRIAL ; RANDOMIZED-TRIAL ; STAGING SYSTEM ; 7TH EDITION ; CISPLATIN ; DOCETAXEL ; CHEMORADIOTHERAPY ; GEMCITABINE ; FLUOROURACIL
收录类别	SCI
语种	英语
资助项目	Medical and Health Science and Technology Program of Zhejiang Province[2020KY084] ; Medical and Health Science and Technology Program of Zhejiang Province[2019KY041] ; Medical and Health Science and Technology Program of Zhejiang Province[2013KYB033] ; Medical and Health Science and Technology Program of Zhejiang Province[2009B026] ; Medical and Health Science and Technology Program of Zhejiang Province[2006A016] ; Medical and Health Science and Technology Program of Zhejiang Province[2005B012] ; Medical and Health Science and Technology Program of Zhejiang Province[2004B014] ; National Natural Science Foundation of China[81502646] ; National Natural Science Foundation of China[81502647]
项目资助者	Medical and Health Science and Technology Program of Zhejiang Province ; National Natural Science Foundation of China
WOS研究方向	General & Internal Medicine
WOS类目	Medicine, General & Internal
WOS记录号	WOS:000579445400031
出版者	LIPPINCOTT WILLIAMS & WILKINS
引用统计	被引频次：6[WOS] [WOS记录] [WOS相关记录]
文献类型	期刊论文
条目标识符	http://ir.hfcas.ac.cn:8080/handle/334002/104525
专题	中国科学院合肥物质科学研究院
通讯作者	Wang, Fangzheng; Jiang Yangming
作者单位	1.Univ Chinese Acad Sci, Canc Hosp, Dept Radiat Oncol, Hangzhou, Zhejiang, Peoples R China 2.Zhejiang Canc Hosp, Dept Radiat Oncol, Hangzhou, Zhejiang, Peoples R China 3.Chinese Acad Sci, Inst Canc Res & Basic Med Sci, Hangzhou, Zhejiang, Peoples R China 4.Zhejiang Canc Hosp, Zhejiang Key Lab Radiat Oncol, Hangzhou, Zhejiang, Peoples R China 5.Zhejiang Canc Hosp, Dept Breast Tumor Surg, Hangzhou, Zhejiang, Peoples R China 6.Chinese Acad Sci, Inst Remote Sensing & Digital Earth, Dept Digital Earth, Beijing, Peoples R China
推荐引用方式 GB/T 7714	Wang, Fangzheng,Jiang Chuner,Wang Lei,et al. Optimal induction chemotherapeutic regimen followed by concurrent chemotherapy plus intensity-modulated radiotherapy as first-line therapy for locoregionally advanced nasopharyngeal carcinoma[J]. MEDICINE,2020,99.
APA	Wang, Fangzheng.,Jiang Chuner.,Wang Lei.,Yan Fengqin.,Ye Zhimin.,...&Jiang Yangming.(2020).Optimal induction chemotherapeutic regimen followed by concurrent chemotherapy plus intensity-modulated radiotherapy as first-line therapy for locoregionally advanced nasopharyngeal carcinoma.MEDICINE,99.
MLA	Wang, Fangzheng,et al."Optimal induction chemotherapeutic regimen followed by concurrent chemotherapy plus intensity-modulated radiotherapy as first-line therapy for locoregionally advanced nasopharyngeal carcinoma".MEDICINE 99(2020).